当前位置: X-MOL 学术CA: Cancer J. Clin. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review
CA: A Cancer Journal for Clinicians ( IF 254.7 ) Pub Date : 2022-08-15 , DOI: 10.3322/caac.21753
Catherine Constable 1, 2 , Kyle Ferguson 2 , Joey Nicholson 3 , Gwendolyn P Quinn 2, 4
Affiliation  

Human papillomavirus (HPV) is currently linked to almost 35,000 new cases of cancer in women and men each year in the United States. Gardasil-9 (Merck & Company), the only HPV vaccine now available in the United States, is nearly 100% effective at preventing precancers caused by oncogenic HPV types. In the United States, however, only about one half of adolescents are up to date with HPV vaccination. It is well known that health care clinicians’ recommendations play a significant role in parents’ decisions regarding HPV vaccination. A growing body of literature examines specific communication strategies for promoting uptake of the HPV vaccine. A comprehensive review of the evidence for each of these strategies is needed. The authors searched the PubMed, EMBASE, Cochrane Central Register of Controlled Trials, PsycINFO, Cumulative Index to Nursing and Allied Health Literature, and Web of Science Complete databases for original articles with a defined clinician communication strategy and an outcome of HPV vaccine uptake or intention to vaccinate (PROSPERO registry no. CRD42020107602). In total, 46 studies were included. The authors identified two main strategies with strong evidence supporting their positive impact on vaccine uptake: strong recommendation and presumptive recommendation. Determinations about a causal relationship were limited by the small numbers of randomized controlled trials. There is also opportunity for more research to determine the effects of motivational interviewing and cancer-prevention messaging.

中文翻译:

与人乳头瘤病毒 (HPV) 疫苗接种增加相关的临床医生沟通策略:系统评价

人乳头瘤病毒 (HPV) 目前与美国每年近 35,000 例女性和男性新发癌症病例有关。Gardasil-9(默克公司)是目前美国唯一可用的 HPV 疫苗,在预防由致癌 HPV 类型引起的癌前病变方面几乎 100% 有效。然而,在美国,只有大约一半的青少年接种了 HPV 疫苗。众所周知,医疗保健临床医生的建议在父母关于 HPV 疫苗接种的决定中起着重要作用。越来越多的文献研究了促进 HPV 疫苗接种的具体沟通策略。需要对每种策略的证据进行全面审查。作者检索了 PubMed、EMBASE、Cochrane 对照试验中心注册库、PsycINFO、Cumulative Index to Cursing and Allied Health Literature 和 Web of Science 原始文章的完整数据库,具有明确的临床医生沟通策略和 HPV 疫苗接种或接种意向的结果(PROSPERO 注册号 CRD42020107602)。总共包括 46 项研究。作者确定了两种主要策略,并有强有力的证据支持它们对疫苗接种产生积极影响:强烈推荐推定推荐。关于因果关系的确定受到少量随机对照试验的限制。还有机会进行更多研究,以确定动机访谈和癌症预防信息的影响。
更新日期:2022-08-15
down
wechat
bug